TY - JOUR
T1 - A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells
AU - West, Robert B.
AU - Rubin, Brian P.
AU - Miller, Melinda A.
AU - Subramanian, Subbaya
AU - Kaygusuz, Gulsah
AU - Montgomery, Kelli
AU - Zhu, Shirley
AU - Marinelli, Robert J.
AU - De Luca, Alessandro
AU - Downs-Kelly, Erinn
AU - Goldblum, John R.
AU - Corless, Christopher L.
AU - Brown, Patrick O.
AU - Gilks, C. Blake
AU - Nielsen, Torsten O.
AU - Huntsman, David
AU - Van De Rijn, Matt
PY - 2006/1/17
Y1 - 2006/1/17
N2 - Tenosynovial giant-cell tumor (TGCT) and pigmented villonodular synovitis (PVNS) are related conditions with features of both reactive inflammatory disorders and clonal neoplastic proliferations. Chromosomal translocations involving chromosome 1p13 have been reported in both TGCT and PVNS. We confirm that translocations involving 1p13 are present in a majority of cases of TGCT and PVNS and show that CSF1 is the gene at the chromosome 1p13 breakpoint. In some cases of both TGCT and PVNS, CSF1 is fused to COL6A3 (2q35). The CSF1 translocations result in overexpression of CSF1. In cases of TGCT and PVNS carrying this translocation, it is present in a minority of the intratumoral cells, leading to CSF1 expression only in these cells, whereas the majority of cells express CSF1R but not CSF1, suggesting a tumor-landscaping effect with aberrant CSF1 expression in the neoplastic cells, leading to the abnormal accumulation of nonneoplastic cells that form a tumorous mass.
AB - Tenosynovial giant-cell tumor (TGCT) and pigmented villonodular synovitis (PVNS) are related conditions with features of both reactive inflammatory disorders and clonal neoplastic proliferations. Chromosomal translocations involving chromosome 1p13 have been reported in both TGCT and PVNS. We confirm that translocations involving 1p13 are present in a majority of cases of TGCT and PVNS and show that CSF1 is the gene at the chromosome 1p13 breakpoint. In some cases of both TGCT and PVNS, CSF1 is fused to COL6A3 (2q35). The CSF1 translocations result in overexpression of CSF1. In cases of TGCT and PVNS carrying this translocation, it is present in a minority of the intratumoral cells, leading to CSF1 expression only in these cells, whereas the majority of cells express CSF1R but not CSF1, suggesting a tumor-landscaping effect with aberrant CSF1 expression in the neoplastic cells, leading to the abnormal accumulation of nonneoplastic cells that form a tumorous mass.
KW - COL6A3
KW - Macrophage
KW - Pigmented villonodular synovitis
KW - Receptor tyrosine kinase
UR - http://www.scopus.com/inward/record.url?scp=31444433318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31444433318&partnerID=8YFLogxK
U2 - 10.1073/pnas.0507321103
DO - 10.1073/pnas.0507321103
M3 - Article
C2 - 16407111
AN - SCOPUS:31444433318
SN - 0027-8424
VL - 103
SP - 690
EP - 695
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 3
ER -